SLC14A1: a novel target for human urothelial cancer

go back to reference American Cancer Society. Cancer facts and figures 2016. Atlanta: American Cancer Society; 2016. American Cancer Society. Cancer facts and figures 2016. Atlanta: American Cancer Society; 2016.

go back to reference Karaoglu I, van der Heijden AG, Witjes JA. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer. World J Urol. 2014;32(3):651–9. doi:10.1007/s00345-013-1035-1.PubMed Karaoglu I, van der Heijden AG, Witjes JA. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer. World J Urol. 2014;32(3):651–9. doi:10.​1007/​s00345-013-1035-1.PubMed

go back to reference Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F, Heim S. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromosomes Cancer. 2000;29(3):256–65.CrossRefPubMed Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F, Heim S. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromosomes Cancer. 2000;29(3):256–65.CrossRefPubMed

go back to reference Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS. Urologic Diseases in America Project. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013;119(17):3219–27. doi:10.1002/cncr.28147.CrossRefPubMedPubMedCentral Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS. Urologic Diseases in America Project. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013;119(17):3219–27. doi:10.​1002/​cncr.​28147.CrossRefPubMedPubMedCentral

go back to reference Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, Lotan Y. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–62. doi:10.1016/j.eururo.2014.01.006.CrossRefPubMed Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, Lotan Y. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–62. doi:10.​1016/​j.​eururo.​2014.​01.​006.CrossRefPubMed

go back to reference Knowles MA. Molecular pathogenesis of bladder cancer. Int J Clin Oncol. 2008;13(4):287–97. doi:10.1007/s10147-008-0812-0.CrossRefPubMed Knowles MA. Molecular pathogenesis of bladder cancer. Int J Clin Oncol. 2008;13(4):287–97. doi:10.​1007/​s10147-008-0812-0.CrossRefPubMed

go back to reference Schulz WA. Understanding urothelial carcinoma through cancer pathways. Int J Cancer. 2006;119(7):1513–8. doi:10.1002/ijc.21852.CrossRefPubMed Schulz WA. Understanding urothelial carcinoma through cancer pathways. Int J Cancer. 2006;119(7):1513–8. doi:10.​1002/​ijc.​21852.CrossRefPubMed

go back to reference Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Role of chromosome 9 in human bladder cancer. Cancer Res. 1993;53(17):4066–70.PubMed Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Role of chromosome 9 in human bladder cancer. Cancer Res. 1993;53(17):4066–70.PubMed

go back to reference Iyer G, Milowsky MI. Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol Oncol. 2013;31(3):303–11. doi:10.1016/j.urolonc.2011.12.001.CrossRefPubMed Iyer G, Milowsky MI. Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol Oncol. 2013;31(3):303–11. doi:10.​1016/​j.​urolonc.​2011.​12.​001.CrossRefPubMed

go back to reference Pandith AA, Shah ZA, Siddiqi MA. Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer. Urol Oncol. 2013;31(4):398–406. doi:10.1016/j.urolonc.2010.07.014.CrossRefPubMed Pandith AA, Shah ZA, Siddiqi MA. Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer. Urol Oncol. 2013;31(4):398–406. doi:10.​1016/​j.​urolonc.​2010.​07.​014.CrossRefPubMed

go back to reference Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG, Benedict WF. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res. 1998;58(6):1090–4.PubMed Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG, Benedict WF. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res. 1998;58(6):1090–4.PubMed

go back to reference Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol. 2006;24(35):5552–64. doi:10.1200/JCO.2006.08.2073.CrossRefPubMed Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol. 2006;24(35):5552–64. doi:10.​1200/​JCO.​2006.​08.​2073.CrossRefPubMed

go back to reference Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68(4):820–3.CrossRefPubMedPubMedCentral Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68(4):820–3.CrossRefPubMedPubMedCentral

go back to reference Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni JF Jr, Silverman DT, Chanock SJ, Wu X. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet. 2011;20(21):4282–9. doi:10.1093/hmg/ddr342.CrossRefPubMedPubMedCentral Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni JF Jr, Silverman DT, Chanock SJ, Wu X. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet. 2011;20(21):4282–9. doi:10.​1093/​hmg/​ddr342.CrossRefPubMedPubMedCentral

go back to reference Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsbergen-van de Kaa CA, Besenbacher S, Gudbjartsson D, Stacey SN, Gudmundsson J, Johannsdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvadottir L, Jonsson E, Geirsson G, Nikulasson S, Petursdottir V, Bishop DT, Chung-Sak S, Choudhury A, Elliott F, Barrett JH, Knowles MA, de Verdier PJ, Ryk C, Lindblom A, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Panadero A, Sanz-Velez JI, Sanchez M, Valdivia G, Garcia-Prats MD, Hengstler JG, Selinski S, Gerullis H, Ovsiannikov D, Khezri A, Aminsharifi A, Malekzadeh M, van den Berg LH, Ophoff RA, Veldink JH, Zeegers MP, Kellen E, Fostinelli J, Andreoli D, Arici C, Porru S, Buntinx F, Ghaderi A, Golka K, Mayordomo JI, Matullo G, Kumar R, Steineck G, Kiltie AE, Kong A, Thorsteinsdottir U, Stefansson K, Kiemeney LA. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet. 2011;20(21):4268–81. doi:10.1093/hmg/ddr303.CrossRefPubMedPubMedCentral Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsbergen-van de Kaa CA, Besenbacher S, Gudbjartsson D, Stacey SN, Gudmundsson J, Johannsdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvadottir L, Jonsson E, Geirsson G, Nikulasson S, Petursdottir V, Bishop DT, Chung-Sak S, Choudhury A, Elliott F, Barrett JH, Knowles MA, de Verdier PJ, Ryk C, Lindblom A, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Panadero A, Sanz-Velez JI, Sanchez M, Valdivia G, Garcia-Prats MD, Hengstler JG, Selinski S, Gerullis H, Ovsiannikov D, Khezri A, Aminsharifi A, Malekzadeh M, van den Berg LH, Ophoff RA, Veldink JH, Zeegers MP, Kellen E, Fostinelli J, Andreoli D, Arici C, Porru S, Buntinx F, Ghaderi A, Golka K, Mayordomo JI, Matullo G, Kumar R, Steineck G, Kiltie AE, Kong A, Thorsteinsdottir U, Stefansson K, Kiemeney LA. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet. 2011;20(21):4268–81. doi:10.​1093/​hmg/​ddr303.CrossRefPubMedPubMedCentral

go back to reference Singh V, Jaiswal PK, Mittal RD. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians. Urol Oncol. 2014;32(8):1209–14. doi:10.1016/j.urolonc.2014.05.013.CrossRefPubMed Singh V, Jaiswal PK, Mittal RD. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians. Urol Oncol. 2014;32(8):1209–14. doi:10.​1016/​j.​urolonc.​2014.​05.​013.CrossRefPubMed

go back to reference Matsuda K, Takahashi A, Middlebrooks CD, Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C, Cui R, Figueroa JD, Silverman DT, Rothman N, Namiki M, Tomita Y, Nishiyama H, Kohri K, Deguchi T, Nakagawa M, Yokoyama M, Miki T, Kumon H, Fujioka T, Prokunina-Olsson L, Kubo M, Nakamura Y, Shuin T. Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum Mol Genet. 2015;24(4):1177–84. doi:10.1093/hmg/ddu512.CrossRefPubMed Matsuda K, Takahashi A, Middlebrooks CD, Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C, Cui R, Figueroa JD, Silverman DT, Rothman N, Namiki M, Tomita Y, Nishiyama H, Kohri K, Deguchi T, Nakagawa M, Yokoyama M, Miki T, Kumon H, Fujioka T, Prokunina-Olsson L, Kubo M, Nakamura Y, Shuin T. Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum Mol Genet. 2015;24(4):1177–84. doi:10.​1093/​hmg/​ddu512.CrossRefPubMed

go back to reference Lucien N, Sidoux-Walter F, Olivès B, Moulds J, Le Pennec PY, Cartron JP, Bailly P. Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals. J Biol Chem. 1998;273(21):12973–80. doi:10.1074/jbc.273.21.12973.CrossRefPubMed Lucien N, Sidoux-Walter F, Olivès B, Moulds J, Le Pennec PY, Cartron JP, Bailly P. Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals. J Biol Chem. 1998;273(21):12973–80. doi:10.​1074/​jbc.​273.​21.​12973.CrossRefPubMed

go back to reference Shayakul C, Hediger MA. The SLC14 gene family of urea transporters. Pflugers Arch. 2004;447(5):603–9. doi:10.1007/s00424-003-1124-x.CrossRefPubMed Shayakul C, Hediger MA. The SLC14 gene family of urea transporters. Pflugers Arch. 2004;447(5):603–9. doi:10.​1007/​s00424-003-1124-x.CrossRefPubMed

go back to reference Sands JM. Molecular mechanisms of urea transport. J Membr Biol. 2003;191(3):149–63. doi:10.1007/s00232-002-1053-1.CrossRefPubMed Sands JM. Molecular mechanisms of urea transport. J Membr Biol. 2003;191(3):149–63. doi:10.​1007/​s00232-002-1053-1.CrossRefPubMed

go back to reference Yang B. Transport characteristics of urea transporter-B. Subcell Biochem. 2014;73:127–35. doi:10.1007/978-94-017-9343-8_8.CrossRefPubMed Yang B. Transport characteristics of urea transporter-B. Subcell Biochem. 2014;73:127–35. doi:10.​1007/​978-94-017-9343-8_​8.CrossRefPubMed

go back to reference Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem. 1994;269(50):31649–52.PubMed Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem. 1994;269(50):31649–52.PubMed

go back to reference Timmer RT, Klein JD, Bagnasco SM, Doran JJ, Verlander JW, Gunn RB, Sands JM. Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues. Am J Physiol Cell Physiol. 2001;281(4):1318–25. Timmer RT, Klein JD, Bagnasco SM, Doran JJ, Verlander JW, Gunn RB, Sands JM. Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues. Am J Physiol Cell Physiol. 2001;281(4):1318–25.

go back to reference Li X, Ran J, Zhou H, Lei T, Zhou L, Han J, Yang B. Mice lacking urea transporter UT-B display depression-like behavior. J Mol Neurosci. 2012;46(2):362–72. doi:10.1007/s12031-011-9594-3.CrossRefPubMed Li X, Ran J, Zhou H, Lei T, Zhou L, Han J, Yang B. Mice lacking urea transporter UT-B display depression-like behavior. J Mol Neurosci. 2012;46(2):362–72. doi:10.​1007/​s12031-011-9594-3.CrossRefPubMed

go back to reference Walpole C, Farrell A, McGrane A, Stewart GS. Expression and localization of a UT-B urea transporter in the human bladder. Am J Physiol Renal Physiol. 2014;307(9):1088–94. doi:10.1152/ajprenal.00284.2014.CrossRef Walpole C, Farrell A, McGrane A, Stewart GS. Expression and localization of a UT-B urea transporter in the human bladder. Am J Physiol Renal Physiol. 2014;307(9):1088–94. doi:10.​1152/​ajprenal.​00284.​2014.CrossRef

go back to reference Vaarala MH, Hirvikoski P, Kauppila S, Paavonen TK. Identification of androgen-regulated genes in human prostate. Mol Med Rep. 2012;6(3):466–72. doi:10.3892/mmr.2012.956.CrossRefPubMedPubMedCentral Vaarala MH, Hirvikoski P, Kauppila S, Paavonen TK. Identification of androgen-regulated genes in human prostate. Mol Med Rep. 2012;6(3):466–72. doi:10.​3892/​mmr.​2012.​956.CrossRefPubMedPubMedCentral

go back to reference Frullanti E, Colombo F, Falvella FS, Galvan A, Noci S, De Cecco L, Incarbone M, Alloisio M, Santambrogio L, Nosotti M, Tosi D, Pastorino U, Dragani TA. Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int J Cancer. 2012;131(5):643–8. doi:10.1002/ijc.27426.CrossRef Frullanti E, Colombo F, Falvella FS, Galvan A, Noci S, De Cecco L, Incarbone M, Alloisio M, Santambrogio L, Nosotti M, Tosi D, Pastorino U, Dragani TA. Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int J Cancer. 2012;131(5):643–8. doi:10.​1002/​ijc.​27426.CrossRef

go back to reference Stewart GS, Graham C, Cattell S, Smith TP, Simmons NL, Smith CP. UT-B is expressed in bovine rumen: potential role in ruminal urea transport. Am J Physiol Regul Integr Comp Physiol. 2005;289(2):605–12. doi:10.1152/ajpregu.00127.2005.CrossRef Stewart GS, Graham C, Cattell S, Smith TP, Simmons NL, Smith CP. UT-B is expressed in bovine rumen: potential role in ruminal urea transport. Am J Physiol Regul Integr Comp Physiol. 2005;289(2):605–12. doi:10.​1152/​ajpregu.​00127.​2005.CrossRef

go back to reference Stewart G. The emerging physiological roles of the SLC14A family of urea transporters. Br J Pharmacol. 2011;164(7):1780–92. doi:10.1111/j.1476-5381.2011.01377.x.CrossRefPubMedPubMedCentral Stewart G. The emerging physiological roles of the SLC14A family of urea transporters. Br J Pharmacol. 2011;164(7):1780–92. doi:10.​1111/​j.​1476-5381.​2011.​01377.​x.CrossRefPubMedPubMedCentral

go back to reference Olivès B, Martial S, Mattei MG, Matassi G, Rousselet G, Ripoche P, Cartron JP, Bailly P. Molecular characterization of a new urea transporter in the human kidney. FEBS Lett. 1996;386(2–3):156–60.CrossRefPubMed Olivès B, Martial S, Mattei MG, Matassi G, Rousselet G, Ripoche P, Cartron JP, Bailly P. Molecular characterization of a new urea transporter in the human kidney. FEBS Lett. 1996;386(2–3):156–60.CrossRefPubMed

go back to reference Sidoux-Walter F, Lucien N, Nissinen R, Sistonen P, Henry S, Moulds J, Cartron JP, Bailly P. Molecular heterogeneity of the Jk(null) phenotype: expression analysis of the Jk(S291P) mutation found in Finns. Blood. 2000;96(4):1566–73.PubMed Sidoux-Walter F, Lucien N, Nissinen R, Sistonen P, Henry S, Moulds J, Cartron JP, Bailly P. Molecular heterogeneity of the Jk(null) phenotype: expression analysis of the Jk(S291P) mutation found in Finns. Blood. 2000;96(4):1566–73.PubMed

go back to reference Lucien N, Sidoux-Walter F, Roudier N, Ripoche P, Huet M, Trinh-Trang-Tan MM, Cartron JP, Bailly P. Antigenic and functional properties of the human red blood cell urea transporter hUT-B1. J Biol Chem. 2002;277(37):34101–8. doi:10.1074/jbc.M205073200.CrossRefPubMed Lucien N, Sidoux-Walter F, Roudier N, Ripoche P, Huet M, Trinh-Trang-Tan MM, Cartron JP, Bailly P. Antigenic and functional properties of the human red blood cell urea transporter hUT-B1. J Biol Chem. 2002;277(37):34101–8. doi:10.​1074/​jbc.​M205073200.CrossRefPubMed

go back to reference Olivès B, Mattei MG, Huet M, Neau P, Martial S, Cartron JP, Bailly P. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem. 1995;270(26):15607–10.CrossRefPubMed Olivès B, Mattei MG, Huet M, Neau P, Martial S, Cartron JP, Bailly P. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem. 1995;270(26):15607–10.CrossRefPubMed

go back to reference Lucien N, Bruneval P, Lasbennes F, Belair MF, Mandet C, Cartron J, Bailly P, Trinh-Trang-Tan MM. UT-B1 urea transporter is expressed along the urinary and gastrointestinal tracts of the mouse. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):1046–56. doi:10.1152/ajpregu.00286.2004.CrossRef Lucien N, Bruneval P, Lasbennes F, Belair MF, Mandet C, Cartron J, Bailly P, Trinh-Trang-Tan MM. UT-B1 urea transporter is expressed along the urinary and gastrointestinal tracts of the mouse. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):1046–56. doi:10.​1152/​ajpregu.​00286.​2004.CrossRef

go back to reference Spector DA, Yang Q, Liu J, Wade JB. Expression, localization, and regulation of urea transporter B in rat urothelia. Am J Physiol Renal Physiol. 2004;287(1):102–8. doi:10.1152/ajprenal.00442.2003.CrossRef Spector DA, Yang Q, Liu J, Wade JB. Expression, localization, and regulation of urea transporter B in rat urothelia. Am J Physiol Renal Physiol. 2004;287(1):102–8. doi:10.​1152/​ajprenal.​00442.​2003.CrossRef

go back to reference Sands JM, Blount MA. Genes and proteins of urea transporters. Subcell Biochem. 2014;73:45–63. doi:10.1007/978-94-017-9343-8_4.CrossRefPubMed Sands JM, Blount MA. Genes and proteins of urea transporters. Subcell Biochem. 2014;73:45–63. doi:10.​1007/​978-94-017-9343-8_​4.CrossRefPubMed

go back to reference Levin EJ, Quick M, Zhou M. Crystal structure of a bacterial homologue of the kidney urea transporter. Nature. 2009;462(7274):757–61. doi:10.1038/nature08558.CrossRefPubMedPubMedCentral Levin EJ, Quick M, Zhou M. Crystal structure of a bacterial homologue of the kidney urea transporter. Nature. 2009;462(7274):757–61. doi:10.​1038/​nature08558.CrossRefPubMedPubMedCentral

go back to reference Levin EJ, Cao Y, Enkavi G, Quick M, Pan Y, Tajkhorshid E, Zhou M. Structure and permeation mechanism of a mammalian urea transporter. Proc Natl Acad Sci USA. 2012;109(28):11194–9. doi:10.1073/pnas.1207362109.CrossRefPubMedPubMedCentral Levin EJ, Cao Y, Enkavi G, Quick M, Pan Y, Tajkhorshid E, Zhou M. Structure and permeation mechanism of a mammalian urea transporter. Proc Natl Acad Sci USA. 2012;109(28):11194–9. doi:10.​1073/​pnas.​1207362109.CrossRefPubMedPubMedCentral

go back to reference Knepper MA, Mindell JA. Structural biology: molecular coin slots for urea. Nature. 2009;462(7274):733–4. doi:10.1038/462733a.CrossRefPubMed Knepper MA, Mindell JA. Structural biology: molecular coin slots for urea. Nature. 2009;462(7274):733–4. doi:10.​1038/​462733a.CrossRefPubMed

go back to reference Gallucci E, Micelli S, Lippe C. Non-electrolyte permeability across thin lipid membranes. Arch Int Physiol Biochim. 1971;79(5):881–7.PubMed Gallucci E, Micelli S, Lippe C. Non-electrolyte permeability across thin lipid membranes. Arch Int Physiol Biochim. 1971;79(5):881–7.PubMed

go back to reference Yang B, Bankir L, Gillespie A, Epstein CJ, Verkman AS. Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem. 2002;277(12):10633–7. doi:10.1074/jbc.M200207200.CrossRefPubMed Yang B, Bankir L, Gillespie A, Epstein CJ, Verkman AS. Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem. 2002;277(12):10633–7. doi:10.​1074/​jbc.​M200207200.CrossRefPubMed

go back to reference Li X, Chen G, Yang B. Urea transporter physiology studied in knockout mice. Front Physiol. 2012;3:217. doi:10.3389/fphys.2012.00217.PubMedPubMedCentral Li X, Chen G, Yang B. Urea transporter physiology studied in knockout mice. Front Physiol. 2012;3:217. doi:10.​3389/​fphys.​2012.​00217.PubMedPubMedCentral

go back to reference Klein JD, Fröhlich O, Blount MA, Martin CF, Smith TD, Sands JM. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol. 2006;17(10):2680–6. doi:10.1681/ASN.2006030246.CrossRefPubMed Klein JD, Fröhlich O, Blount MA, Martin CF, Smith TD, Sands JM. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol. 2006;17(10):2680–6. doi:10.​1681/​ASN.​2006030246.CrossRefPubMed

go back to reference Cai Q, Nelson SK, McReynolds MR, Diamond-Stanic MK, Elliott D, Brooks HL. Vasopressin increases expression of UT-A1, UT-A3, and ER chaperone GRP78 in the renal medulla of mice with a urinary concentrating defect. Am J Physiol Renal Physiol. 2010;299(4):712–9. doi:10.1152/ajprenal.00690.2009.CrossRef Cai Q, Nelson SK, McReynolds MR, Diamond-Stanic MK, Elliott D, Brooks HL. Vasopressin increases expression of UT-A1, UT-A3, and ER chaperone GRP78 in the renal medulla of mice with a urinary concentrating defect. Am J Physiol Renal Physiol. 2010;299(4):712–9. doi:10.​1152/​ajprenal.​00690.​2009.CrossRef

go back to reference Klein JD, Blount MA, Sands JM. Molecular mechanisms of urea transport in health and disease. Pflugers Arch. 2012;464(6):561–72. doi:10.1007/s00424-012-1157-0.CrossRefPubMedPubMedCentral Klein JD, Blount MA, Sands JM. Molecular mechanisms of urea transport in health and disease. Pflugers Arch. 2012;464(6):561–72. doi:10.​1007/​s00424-012-1157-0.CrossRefPubMedPubMedCentral

go back to reference Klein JD, Blount MA, Sands JM. Urea transport in the kidney. Compr Physiol. 2011;1(2):699–729. doi:10.1002/cphy.c100030.PubMed Klein JD, Blount MA, Sands JM. Urea transport in the kidney. Compr Physiol. 2011;1(2):699–729. doi:10.​1002/​cphy.​c100030.PubMed

go back to reference Guo L, Zhao D, Song Y, Meng Y, Zhao H, Zhao X, Yang B. Reduced urea flux across the blood-testis barrier and early maturation in the male reproductive system in UT-B-null mice. Am J Physiol Cell Physiol. 2007;293(1):305–12. doi:10.1152/ajpcell.00608.2006.CrossRef Guo L, Zhao D, Song Y, Meng Y, Zhao H, Zhao X, Yang B. Reduced urea flux across the blood-testis barrier and early maturation in the male reproductive system in UT-B-null mice. Am J Physiol Cell Physiol. 2007;293(1):305–12. doi:10.​1152/​ajpcell.​00608.​2006.CrossRef

go back to reference Yang B, Bankir L. Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol. 2005;288(5):881–96. doi:10.1152/ajprenal.00367.2004.CrossRef Yang B, Bankir L. Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol. 2005;288(5):881–96. doi:10.​1152/​ajprenal.​00367.​2004.CrossRef

go back to reference Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004;5(3):117–28. doi:10.1046/j.1600-0854.2003.00156.x.CrossRefPubMed Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004;5(3):117–28. doi:10.​1046/​j.​1600-0854.​2003.​00156.​x.CrossRefPubMed

go back to reference Dong Z, Ran J, Zhou H, Chen J, Lei T, Wang W, Sun Y, Lin G, Bankir L, Yang B. Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder urothelium. PLoS One. 2013;8(10):e76952. doi:10.1371/journal.pone.0076952.CrossRefPubMedPubMedCentral Dong Z, Ran J, Zhou H, Chen J, Lei T, Wang W, Sun Y, Lin G, Bankir L, Yang B. Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder urothelium. PLoS One. 2013;8(10):e76952. doi:10.​1371/​journal.​pone.​0076952.CrossRefPubMedPubMedCentral

go back to reference Michea L, Ferguson DR, Peters EM, Andrews PM, Kirby MR, Burg MB. Cell cycle delay and apoptosis are induced by high salt and urea in renal medullary cells. Am J Physiol Renal Physiol. 2000;278(2):209–18. Michea L, Ferguson DR, Peters EM, Andrews PM, Kirby MR, Burg MB. Cell cycle delay and apoptosis are induced by high salt and urea in renal medullary cells. Am J Physiol Renal Physiol. 2000;278(2):209–18.

go back to reference Zou Q, Habermann-Rottinghaus SM, Murphy KP. Urea effects on protein stability: hydrogen bonding and the hydrophobic effect. Proteins. 1998;31(2):107–15.CrossRefPubMed Zou Q, Habermann-Rottinghaus SM, Murphy KP. Urea effects on protein stability: hydrogen bonding and the hydrophobic effect. Proteins. 1998;31(2):107–15.CrossRefPubMed

go back to reference Martin JW, Carballido EM, Ahmed A, Farhan B, Dutta R, Smith C, Youssef RF. Squamous cell carcinoma of the urinary bladder: systematic review of clinical characteristics and therapeutic approaches. Arab J Urol. 2016;14(3):183–91. doi:10.1016/j.aju.2016.07.001.CrossRefPubMedPubMedCentral Martin JW, Carballido EM, Ahmed A, Farhan B, Dutta R, Smith C, Youssef RF. Squamous cell carcinoma of the urinary bladder: systematic review of clinical characteristics and therapeutic approaches. Arab J Urol. 2016;14(3):183–91. doi:10.​1016/​j.​aju.​2016.​07.​001.CrossRefPubMedPubMedCentral

go back to reference Dadhania V, Czerniak B, Guo CC. Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol. 2015;3(2):51–63.PubMedPubMedCentral Dadhania V, Czerniak B, Guo CC. Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol. 2015;3(2):51–63.PubMedPubMedCentral

go back to reference Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: pathology. Eur Urol. 2013;63(1):16–35. doi:10.1016/j.eururo.2012.09.063.CrossRefPubMed Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: pathology. Eur Urol. 2013;63(1):16–35. doi:10.​1016/​j.​eururo.​2012.​09.​063.CrossRefPubMed

go back to reference Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009;4:251–85. doi:10.1146/annurev.pathol.4.110807.092230.CrossRefPubMed Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009;4:251–85. doi:10.​1146/​annurev.​pathol.​4.​110807.​092230.CrossRefPubMed

go back to reference Böttcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev. 2005;26(1):63–77. doi:10.1210/er.2003-0040.CrossRefPubMed Böttcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev. 2005;26(1):63–77. doi:10.​1210/​er.​2003-0040.CrossRefPubMed

go back to reference Knowles MA. Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target. World J Urol. 2007;25(6):581–93. doi:10.1007/s00345-007-0213-4.CrossRefPubMedPubMedCentral Knowles MA. Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target. World J Urol. 2007;25(6):581–93. doi:10.​1007/​s00345-007-0213-4.CrossRefPubMedPubMedCentral

go back to reference Webster MK, Donoghue DJ. Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain. Mol Cell Biol. 1997;17(10):5739–47.CrossRefPubMedPubMedCentral Webster MK, Donoghue DJ. Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain. Mol Cell Biol. 1997;17(10):5739–47.CrossRefPubMedPubMedCentral

go back to reference Tomlinson DC, Hurst CD, Knowles MA. Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer. Oncogene. 2007;26(40):5889–99. doi:10.1038/sj.onc.1210399.CrossRefPubMedPubMedCentral Tomlinson DC, Hurst CD, Knowles MA. Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer. Oncogene. 2007;26(40):5889–99. doi:10.​1038/​sj.​onc.​1210399.CrossRefPubMedPubMedCentral

go back to reference Bernard-Pierrot I, Brams A, Dunois-Lardé C, Caillault A, Diez de Medina SG, Cappellen D, Graff G, Thiery JP, Chopin D, Ricol D, Radvanyi F. Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b. Carcinogenesis. 2006;27(4):740–7. doi:10.1093/carcin/bgi290.CrossRefPubMed Bernard-Pierrot I, Brams A, Dunois-Lardé C, Caillault A, Diez de Medina SG, Cappellen D, Graff G, Thiery JP, Chopin D, Ricol D, Radvanyi F. Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b. Carcinogenesis. 2006;27(4):740–7. doi:10.​1093/​carcin/​bgi290.CrossRefPubMed

go back to reference Rieger-Christ KM, Mourtzinos A, Lee PJ, Zagha RM, Cain J, Silverman M, Libertino JA, Summerhayes IC. Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer. 2003;98(4):737–44. doi:10.1002/cncr.11536.CrossRefPubMed Rieger-Christ KM, Mourtzinos A, Lee PJ, Zagha RM, Cain J, Silverman M, Libertino JA, Summerhayes IC. Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer. 2003;98(4):737–44. doi:10.​1002/​cncr.​11536.CrossRefPubMed

go back to reference Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323–30.CrossRefPubMed Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323–30.CrossRefPubMed

go back to reference Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366(6456):704–7. doi:10.1038/366704a0.CrossRefPubMed Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366(6456):704–7. doi:10.​1038/​366704a0.CrossRefPubMed

go back to reference Dominguez-Brauer C, Brauer PM, Chen YJ, Pimkina J, Raychaudhuri P. Tumor suppression by ARF: gatekeeper and caretaker. Cell Cycle. 2010;9(1):86–9. doi:10.4161/cc.9.1.10350.CrossRefPubMed Dominguez-Brauer C, Brauer PM, Chen YJ, Pimkina J, Raychaudhuri P. Tumor suppression by ARF: gatekeeper and caretaker. Cell Cycle. 2010;9(1):86–9. doi:10.​4161/​cc.​9.​1.​10350.CrossRefPubMed

go back to reference Inoue K, Fry EA, Frazier DP. Transcription factors that interact with p53 and Mdm2. Int J Cancer. 2016;138(7):1577–85. doi:10.1002/ijc.29663.CrossRefPubMed Inoue K, Fry EA, Frazier DP. Transcription factors that interact with p53 and Mdm2. Int J Cancer. 2016;138(7):1577–85. doi:10.​1002/​ijc.​29663.CrossRefPubMed

go back to reference Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol. 1999;155(1):105–13. doi:10.1016/S0002-9440(10)65105-X.CrossRefPubMedPubMedCentral Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol. 1999;155(1):105–13. doi:10.​1016/​S0002-9440(10)65105-X.CrossRefPubMedPubMedCentral

go back to reference Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res. 2003;9(1):235–42.PubMed Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res. 2003;9(1):235–42.PubMed

go back to reference Aboulkassim TO, LaRue H, Lemieux P, Rousseau F, Fradet Y. Alteration of the PATCHED locus in superficial bladder cancer. Oncogene. 2003;22(19):2967–71. doi:10.1038/sj.onc.1206513.CrossRefPubMed Aboulkassim TO, LaRue H, Lemieux P, Rousseau F, Fradet Y. Alteration of the PATCHED locus in superficial bladder cancer. Oncogene. 2003;22(19):2967–71. doi:10.​1038/​sj.​onc.​1206513.CrossRefPubMed

go back to reference Hamed S, LaRue H, Hovington H, Girard J, Jeannotte L, Latulippe E, Fradet Y. Accelerated induction of bladder cancer in patched heterozygous mutant mice. Cancer Res. 2004;64(6):1938–42.CrossRefPubMed Hamed S, LaRue H, Hovington H, Girard J, Jeannotte L, Latulippe E, Fradet Y. Accelerated induction of bladder cancer in patched heterozygous mutant mice. Cancer Res. 2004;64(6):1938–42.CrossRefPubMed

go back to reference Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer. 1999;26(2):171–5.CrossRefPubMed Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer. 1999;26(2):171–5.CrossRefPubMed

go back to reference Habuchi T, Luscombe M, Elder PA, Knowles MA. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics. 1998;48(3):277–88. doi:10.1006/geno.1997.5165.CrossRefPubMed Habuchi T, Luscombe M, Elder PA, Knowles MA. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics. 1998;48(3):277–88. doi:10.​1006/​geno.​1997.​5165.CrossRefPubMed

go back to reference Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA. Progressive increases in de novo methylation of CpG islands in bladder cancer. Cancer Res. 2000;60(9):2473–6.PubMed Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA. Progressive increases in de novo methylation of CpG islands in bladder cancer. Cancer Res. 2000;60(9):2473–6.PubMed

go back to reference Pymar LS, Platt FM, Askham JM, Morrison EE, Knowles MA. Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms. Hum Mol Genet. 2008;17(13):2006–17. doi:10.1093/hmg/ddn098.CrossRefPubMedPubMedCentral Pymar LS, Platt FM, Askham JM, Morrison EE, Knowles MA. Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms. Hum Mol Genet. 2008;17(13):2006–17. doi:10.​1093/​hmg/​ddn098.CrossRefPubMedPubMedCentral

go back to reference Ching CB, Hansel DE. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Invest. 2010;90(10):1406–14. doi:10.1038/labinvest.2010.133.CrossRefPubMed Ching CB, Hansel DE. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Invest. 2010;90(10):1406–14. doi:10.​1038/​labinvest.​2010.​133.CrossRefPubMed

go back to reference Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Hérault A, Dubois T, Maille P, Soyeux P, Sibony M, de la Taille A, Vordos D, Lebret T, Radvanyi F, Allory Y. PI3K/AKT pathway activation in bladder carcinogenesis. Int J Cancer. 2014;134(8):1776–84. doi:10.1002/ijc.28518.CrossRefPubMed Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Hérault A, Dubois T, Maille P, Soyeux P, Sibony M, de la Taille A, Vordos D, Lebret T, Radvanyi F, Allory Y. PI3K/AKT pathway activation in bladder carcinogenesis. Int J Cancer. 2014;134(8):1776–84. doi:10.​1002/​ijc.​28518.CrossRefPubMed

go back to reference Dueñas M, Martínez-Fernández M, García-Escudero R, Villacampa F, Marqués M, Saiz-Ladera C, Duarte J, Martínez V, Gómez MJ, Martín ML, Fernández M, Castellano D, Real FX, Rodriguez-Peralto JL, De La Rosa F, Paramio JM. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors. Mol Carcinog. 2015;54(7):566–76. doi:10.1002/mc.22125.CrossRefPubMed Dueñas M, Martínez-Fernández M, García-Escudero R, Villacampa F, Marqués M, Saiz-Ladera C, Duarte J, Martínez V, Gómez MJ, Martín ML, Fernández M, Castellano D, Real FX, Rodriguez-Peralto JL, De La Rosa F, Paramio JM. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors. Mol Carcinog. 2015;54(7):566–76. doi:10.​1002/​mc.​22125.CrossRefPubMed

go back to reference Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer. Cancer. 2003;97(8 suppl):2083–9. doi:10.1002/cncr.11281.CrossRefPubMed Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer. Cancer. 2003;97(8 suppl):2083–9. doi:10.​1002/​cncr.​11281.CrossRefPubMed

go back to reference Dalbagni G, Presti JC Jr, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol. 1993;2(1):4–13.CrossRefPubMed Dalbagni G, Presti JC Jr, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol. 1993;2(1):4–13.CrossRefPubMed

go back to reference Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med. 1994;331(19):1259–64. doi:10.1056/NEJM199411103311903.CrossRefPubMed Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med. 1994;331(19):1259–64. doi:10.​1056/​NEJM199411103311​903.CrossRefPubMed

go back to reference Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 1992;70(6):923–35.CrossRefPubMed Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 1992;70(6):923–35.CrossRefPubMed

go back to reference El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–25.CrossRefPubMed El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–25.CrossRefPubMed

go back to reference Stein JP, Ginsberg DA, Grossfeld GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG, Cote RJ. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst. 1998;90(14):1072–9.CrossRefPubMed Stein JP, Ginsberg DA, Grossfeld GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG, Cote RJ. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst. 1998;90(14):1072–9.CrossRefPubMed

go back to reference Li C, Xue H, Lei Y, Zhu J, Yang B, Gai X. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder. Pathol Res Pract. 2014;210(12):799–803. doi:10.1016/j.prp.2014.09.012.CrossRefPubMed Li C, Xue H, Lei Y, Zhu J, Yang B, Gai X. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder. Pathol Res Pract. 2014;210(12):799–803. doi:10.​1016/​j.​prp.​2014.​09.​012.CrossRefPubMed

go back to reference Sidoux-Walter F, Lucien N, Olivès B, Gobin R, Rousselet G, Kamsteeg EJ, Ripoche P, Deen PM, Cartron JP, Bailly P. At physiological expression levels the Kidd blood group/urea transporter protein is not a water channel. J Biol Chem. 1999;274(42):30228–35.CrossRefPubMed Sidoux-Walter F, Lucien N, Olivès B, Gobin R, Rousselet G, Kamsteeg EJ, Ripoche P, Deen PM, Cartron JP, Bailly P. At physiological expression levels the Kidd blood group/urea transporter protein is not a water channel. J Biol Chem. 1999;274(42):30228–35.CrossRefPubMed

go back to reference Koutros S, Baris D, Fischer A, Tang W, Garcia-Closas M, Karagas MR, Schwenn M, Johnson A, Figueroa J, Waddell R, Prokunina-Olsson L, Rothman N, Silverman DT. Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer. 2013;133(12):3008–13. doi:10.1002/ijc.28325.PubMedPubMedCentral Koutros S, Baris D, Fischer A, Tang W, Garcia-Closas M, Karagas MR, Schwenn M, Johnson A, Figueroa J, Waddell R, Prokunina-Olsson L, Rothman N, Silverman DT. Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer. 2013;133(12):3008–13. doi:10.​1002/​ijc.​28325.PubMedPubMedCentral

go back to reference Dirnhuber P, Schütz F. The isomeric transformation of urea into ammonium cyanate in aqueous solutions. Biochem J. 1948;42(4):628–32.CrossRefPubMedCentral Dirnhuber P, Schütz F. The isomeric transformation of urea into ammonium cyanate in aqueous solutions. Biochem J. 1948;42(4):628–32.CrossRefPubMedCentral

go back to reference Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001;78:S102–7. doi:10.1046/j.1523-1755.2001.59780102.x.CrossRefPubMed Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001;78:S102–7. doi:10.​1046/​j.​1523-1755.​2001.​59780102.​x.CrossRefPubMed

go back to reference Lattermann R, Geisser W, Georgieff M, Wachter U, Goertz A, Gnann R, Schricker T. Integrated analysis of glucose, lipid, and urea metabolism in patients with bladder cancer. Impact of tumor stage. Nutrition. 2003;19(7–8):589–92. doi:10.1016/S0899-9007(03)00055-8.CrossRefPubMed Lattermann R, Geisser W, Georgieff M, Wachter U, Goertz A, Gnann R, Schricker T. Integrated analysis of glucose, lipid, and urea metabolism in patients with bladder cancer. Impact of tumor stage. Nutrition. 2003;19(7–8):589–92. doi:10.​1016/​S0899-9007(03)00055-8.CrossRefPubMed

go back to reference Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539–48. doi:10.1038/nrc.2016.58.CrossRefPubMed Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539–48. doi:10.​1038/​nrc.​2016.​58.CrossRefPubMed

go back to reference Ryoo HD, Bergmann A. The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb Perspect Biol. 2012;4(8):a008797. doi:10.1101/cshperspect.a008797.CrossRefPubMedPubMedCentral Ryoo HD, Bergmann A. The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb Perspect Biol. 2012;4(8):a008797. doi:10.​1101/​cshperspect.​a008797.CrossRefPubMedPubMedCentral

go back to reference Mateo J, García-Lecea M, Cadenas S, Hernández C, Moncada S. Regulation of hypoxia-inducible factor-1 alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J. 2003;376(Pt 2):537–44. doi:10.1042/BJ20031155.CrossRefPubMedPubMedCentral Mateo J, García-Lecea M, Cadenas S, Hernández C, Moncada S. Regulation of hypoxia-inducible factor-1 alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J. 2003;376(Pt 2):537–44. doi:10.​1042/​BJ20031155.CrossRefPubMedPubMedCentral

go back to reference Ortiz-Masiá D, Hernández C, Quintana E, Velázquez M, Cebrián S, Riaño A, Calatayud S, Esplugues JV, Barrachina MD. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1. FASEB J. 2010;24(1):136–45. doi:10.1096/fj.09-137489.CrossRefPubMed Ortiz-Masiá D, Hernández C, Quintana E, Velázquez M, Cebrián S, Riaño A, Calatayud S, Esplugues JV, Barrachina MD. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1. FASEB J. 2010;24(1):136–45. doi:10.​1096/​fj.​09-137489.CrossRefPubMed

go back to reference Haines RJ, Pendleton LC, Eichler DC. Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol. 2011;2(1):8–23.PubMed Haines RJ, Pendleton LC, Eichler DC. Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol. 2011;2(1):8–23.PubMed

go back to reference Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, Beltran L, Jones LJ, Chelala C, Wu BW, Bomalaski JS, Jackson RC, Lu YJ, Crook T, Lemoine NR, Mather S, Foster J, Sosabowski J, Avril N, Li CF, Szlosarek PW. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res. 2014;74(3):896–907. doi:10.1158/0008-5472.CAN-13-1702.CrossRefPubMed Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, Beltran L, Jones LJ, Chelala C, Wu BW, Bomalaski JS, Jackson RC, Lu YJ, Crook T, Lemoine NR, Mather S, Foster J, Sosabowski J, Avril N, Li CF, Szlosarek PW. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res. 2014;74(3):896–907. doi:10.​1158/​0008-5472.​CAN-13-1702.CrossRefPubMed

go back to reference Schmid T, Zhou J, Köhl R, Brüne B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J. 2004;380(Pt 1):289–95. doi:10.1042/BJ20031299.CrossRefPubMedPubMedCentral Schmid T, Zhou J, Köhl R, Brüne B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J. 2004;380(Pt 1):289–95. doi:10.​1042/​BJ20031299.CrossRefPubMedPubMedCentral

go back to reference Schmid T, Zhou J, Brüne B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med. 2004;8(4):423–31.CrossRefPubMed Schmid T, Zhou J, Brüne B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med. 2004;8(4):423–31.CrossRefPubMed

go back to reference Blick C, Ramachandran A, Wigfield S, McCormick R, Jubb A, Buffa FM, Turley H, Knowles MA, Cranston D, Catto J, Harris AL. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. Br J Cancer. 2013;109(1):50–9. doi:10.1038/bjc.2013.240.CrossRefPubMedPubMedCentral Blick C, Ramachandran A, Wigfield S, McCormick R, Jubb A, Buffa FM, Turley H, Knowles MA, Cranston D, Catto J, Harris AL. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. Br J Cancer. 2013;109(1):50–9. doi:10.​1038/​bjc.​2013.​240.CrossRefPubMedPubMedCentral

go back to reference Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M. Water intake and bladder cancer risk in Los Angeles County. Int J Cancer. 2008;123(7):1649–56. doi:10.1002/ijc.23711.CrossRefPubMed Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M. Water intake and bladder cancer risk in Los Angeles County. Int J Cancer. 2008;123(7):1649–56. doi:10.​1002/​ijc.​23711.CrossRefPubMed

go back to reference Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer. 2006;118(8):2040–7. doi:10.1002/ijc.21587.CrossRefPubMed Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer. 2006;118(8):2040–7. doi:10.​1002/​ijc.​21587.CrossRefPubMed